Select your location to view local American Lung Association events and news near you.
After raising AU$29 million (US$19.44 million) in a series A round, Rage Biotech Pty Ltd. is beginning phase I trials of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback